Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Cancer prevention has progressed with successful drugs and vaccines, but challenges remain in understanding genetic changes and improving strategies.

The link between anabolic agents and colorectal cancer risk is unclear.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

High DKK1 levels predict worse survival in head and neck cancer.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Cancer prevention is crucial, with a focus on research and improved screening methods.

Cepharanthine shows promise as a natural anticancer treatment.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Copper-quercetin complexes could be effective in treating cancer, infections, and promoting bone healing.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Eclipta alba extract may help fight cancer and has antioxidant benefits without being toxic.

Early screening and HPV vaccination reduce cervical cancer risk.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

Loss of the Y chromosome and UTY gene activity increases cancer risk in men.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.